A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes

Diabetic kidney disease (DKD), a devastating complication of diabetes, is one of the leading causes of end stage kidney disease (ESKD). Kidney transplantation provides superior outcomes for ESKD patients with type 2 diabetes, giving opportunities to be free from dialysis, but needs lifetime immunosu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Sato, Tetsuhiko, Ohara, Emi, Ozone, Chikafumi, Okazaki, Mikako, Fuse, Sachiho, Sasaki, Rie, Azuma, Yoshinori
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Diabetes Mellitus and Glucose Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090345/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.826
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars